PRL and breast cancer: The abnormal proportions of PRL and testosterone in different subtypes of breast cancer were statistically significant (P < 0.01), whereas other four hormones as follicle‐stimulating hormone, estradiol (E2), progesterone, and luteinizing hormone were not significantly different among the four subtypes (P > 0.05) (Figure 2).